The globallactase marketis projected to reach USD 336 million by 2027, at a CAGR of 6.3%, in terms of value, between 2022 and 2027. It is estimated to be valued at USD 247 million in 2022. Lactose is a type of sugar found in milk and other dairy products, lactase is an enzyme that helps in breaking down the milk sugar lactose into simple sugars, namely glucose and galactose. Factors, such as increasing demand for lactose-free and rising product development innovations in other application areas like pharmaceutical, dietary supplements, and infant nutrition are expected to boost the demand for lactase on a global level. Key players in the market are introducing new food products like lactose-free cream, ice cream, and milk alternatives to address the growing lactase-deficient population.
Download PDF Brochure:https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=125332780
Drivers: Growing lactose intolerance in infants and adults
The development of primary lactose intolerance is temporary and found in premature infants before their small intestine is fully developed. Secondary intolerance is seen in adults when they have a digestive issue in the small intestine. Secondary lactose intolerance is triggered by conditions such as Crohns disease or gastroenteritis. According to the National Center for Biotechnology Information (NCBI), nearly 65% of the global population is prone to lactase deficiency. Thus, this has led to an increase in the production of lactose-free dairy products, which helps the lactose-intolerant population to avoid gastrointestinal problems.
Opportunities: Enhanced research and development to find new sources of lactase extraction and enzyme application
There are different sources from which the lactase enzyme is extracted. However, recent research and development are mainly focused on finding newer alternatives like bacteria and fungi as a source to extract the enzyme. Enzymes are also used to improve the nutritional value of food and feed products. In addition, enzymes reduce water consumption and chemical waste and decrease by-product generation, posing negligible risks to humans and the ecosystem. Lactase enzymes obtained from fungal sources have acidic pH and are stable which may have wide application in the food and beverages industry, as it has to undergo different production processes.
By application, the food beverages segment is estimated to occupy the largest market share in terms of value
By application, the food beverages segment is estimated to occupy the largest market share in the lactase market. The lactase enzyme is an enzyme that some people are unable to produce in their small intestines. Without it, lactase-deficient people cannot break down the natural disaccharide in milk. Adding lactase to milk hydrolyzes the lactose naturally found in milk, leaving it slightly sweet but digestible. This property of the enzyme increases its wider application in the food beverages industry.
Request Sample Pages:https://www.marketsandmarkets.com/requestsampleNew.asp?id=125332780
Asia Pacific is projected to grow with the highest CAGR in the lactase market during the forecast period
The Asia Pacific region is projected to grow at the highest CAGR during the forecast period and occupies a significant share in the global lactase market. The increasing awareness regarding lactose intolerance in both adults and infants is gaining momentum in the region. Additionally, the demand for lactose-reduced infant formula and lactose-free products for adult nutrition is significantly catering to the growth of the lactase market in the region. Asia Pacific is also witnessing significant expansion in terms of production by key players operating in the market. The regional manufacturers are currently focusing on new product developments and strategic deals such as partnerships, collaborations, and expansions to create more awareness among consumers and cater to the growing demand.
This report includes a study on the marketing and development strategies, along with the product portfolios of leading companies. It consists of profiles of leading companies, such as CHR. Hansen Holdings A/S (Denmark), Kerry Group plc. (Ireland), Koninklijke DSM N.V. (the Netherlands), Novozymes A/S (Denmark), Merck KGaA (Denmark), IFF (US), Amano Enzymes (Japan), Advanced Enzymes (India), Novact Corporation (US), Antozyme Biotech Pvt. Ltd (India), Nature Biosciences Pvt. Ltd (India), Aumgene Biosciences (India), Creative Enzymes (US), Biolaxi Enzymes Pvt. Ltd (India), Enzyme Biosciences Pvt. Ltd (India), Infinita Biotech (India), Mitushi Biopharma (India), Oenon Holdings Inc. (Japan), Ultreze Enzymes (India), and Senson (Finland)
